December 9-12, 2023 San Diego, California Join us in person at the 65th ASH Annual Meeting and Exposition and learn from the leading experts from Roswell Park Comprehensive Care Center as they present their latest findings in hematology.
Booth: Stop by and visit us at #3411
Sunday, December 12 from 1:00 PM – 5:00 PM
Cocktails and Hors d’Oeuvres
R Place Sports Bar & Grill
315 10th Ave, San Diego Ca 92101
Meet with our Faculty
Featured Presentations from Roswell Park Hematology Experts
Roswell Park Comprehensive Cancer Center experts in both adult and pediatric/adolescent hematology/oncology will share insights during oral abstract sessions at ASH 2023.
Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s Cancer and Blood Disorders Program
Abstract 610, “Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826,”
Sunday, December 10, 2023, at 5:15 p.m. (Session: 624. Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in the Treatment of Hodgkin Lymphoma)
Jens Hillengass, MD, PhD, Professor of Oncology and Internal Medicine at Roswell Park Comprehensive Cancer Center
Abstract 1021 ,”The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1–3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B),”
Monday, December 11, 2023, at 4:30 p.m. (Session: 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: CAR-T Cell Therapies for Multiple Myeloma and B Cell Lymphomas)
Also look for Dr. Hillengass as session chair for 651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Characterization of the MM and the Tumor Microenvironment